Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
Stroke is a major cause of death and adult disability. However, therapeutic options remain limited. Numerous pathways underlie acute responses of brain tissue to stroke. Early events following ischemic damage include reactive oxygen species (ROS)-mediated oxidative stress and glutamate-induced excit...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.01036/full |
id |
doaj-86d2f1045df24411b8dfd5d2327b928f |
---|---|
record_format |
Article |
spelling |
doaj-86d2f1045df24411b8dfd5d2327b928f2020-11-25T02:47:35ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-09-011310.3389/fnins.2019.01036447291Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and InflammationQianwen YangQianyi HuangZhiping HuXiangqi TangStroke is a major cause of death and adult disability. However, therapeutic options remain limited. Numerous pathways underlie acute responses of brain tissue to stroke. Early events following ischemic damage include reactive oxygen species (ROS)-mediated oxidative stress and glutamate-induced excitotoxicity, both of which contribute to rapid cell death within the infarct core. A subsequent cascade of inflammatory events escalates damage progression. This review explores potential neuroprotective strategies for targeting key steps in the cascade of ischemia–reperfusion (I/R) injury. NADPH oxidase (NOX) inhibitors and several drugs currently approved by the U.S. Food and Drug Administration including glucose-lowering agents, antibiotics, and immunomodulators, have shown promise in the treatment of stroke in both animal experiments and clinical trials. Ischemic conditioning, a phenomenon by which one or more cycles of a short period of sublethal ischemia to an organ or tissue protects against subsequent ischemic events in another organ, may be another potential neuroprotective strategy for the treatment of stroke by targeting key steps in the I/R injury cascade.https://www.frontiersin.org/article/10.3389/fnins.2019.01036/fullexcitotoxicityinflammationneuroprotectivepotential treatmentROSstroke |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Qianwen Yang Qianyi Huang Zhiping Hu Xiangqi Tang |
spellingShingle |
Qianwen Yang Qianyi Huang Zhiping Hu Xiangqi Tang Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation Frontiers in Neuroscience excitotoxicity inflammation neuroprotective potential treatment ROS stroke |
author_facet |
Qianwen Yang Qianyi Huang Zhiping Hu Xiangqi Tang |
author_sort |
Qianwen Yang |
title |
Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation |
title_short |
Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation |
title_full |
Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation |
title_fullStr |
Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation |
title_full_unstemmed |
Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation |
title_sort |
potential neuroprotective treatment of stroke: targeting excitotoxicity, oxidative stress, and inflammation |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neuroscience |
issn |
1662-453X |
publishDate |
2019-09-01 |
description |
Stroke is a major cause of death and adult disability. However, therapeutic options remain limited. Numerous pathways underlie acute responses of brain tissue to stroke. Early events following ischemic damage include reactive oxygen species (ROS)-mediated oxidative stress and glutamate-induced excitotoxicity, both of which contribute to rapid cell death within the infarct core. A subsequent cascade of inflammatory events escalates damage progression. This review explores potential neuroprotective strategies for targeting key steps in the cascade of ischemia–reperfusion (I/R) injury. NADPH oxidase (NOX) inhibitors and several drugs currently approved by the U.S. Food and Drug Administration including glucose-lowering agents, antibiotics, and immunomodulators, have shown promise in the treatment of stroke in both animal experiments and clinical trials. Ischemic conditioning, a phenomenon by which one or more cycles of a short period of sublethal ischemia to an organ or tissue protects against subsequent ischemic events in another organ, may be another potential neuroprotective strategy for the treatment of stroke by targeting key steps in the I/R injury cascade. |
topic |
excitotoxicity inflammation neuroprotective potential treatment ROS stroke |
url |
https://www.frontiersin.org/article/10.3389/fnins.2019.01036/full |
work_keys_str_mv |
AT qianwenyang potentialneuroprotectivetreatmentofstroketargetingexcitotoxicityoxidativestressandinflammation AT qianyihuang potentialneuroprotectivetreatmentofstroketargetingexcitotoxicityoxidativestressandinflammation AT zhipinghu potentialneuroprotectivetreatmentofstroketargetingexcitotoxicityoxidativestressandinflammation AT xiangqitang potentialneuroprotectivetreatmentofstroketargetingexcitotoxicityoxidativestressandinflammation |
_version_ |
1724752731034353664 |